Dale R. Kopp

In vivo tests of the E. coli TonB system working model:interaction of ExbB with unknown proteins, identification of TonB-ExbD transmembrane heterodimers and PMF-dependent ExbD structures.

The paper validates aspects of the TonB system working model through in vivo experiments, identifying new ExbB-interacting proteins and PMF-dependent ExbD conformational changes.

Studies on the Escherichia coli ExbD Transmembrane Domain, Residue L132, and an Inhibitory Cyclic Peptide.

This paper investigates the Escherichia coli ExbD transmembrane domain, identifies key residues for TonB system activity, and demonstrates that a cyclic peptide can inhibit ExbD-TonB interaction, suggesting a potential antimicrobial strategy.